Everest Biotech, a manufacturer of novel antibodies for the international research market, has announced the launch of its Antibody Creation Grant.
Worth up to USD100,000 (GBP66,000), the funding is on offer to research laboratories before the deadline of 31 July 2010.
To apply for the grant, applicants need to follow two steps: select 5-50 target proteins for which there is a need for new antibodies and that your laboratory can characterise and fill in and send a short application form, available on Everest Biotech's website.
Everest Biotech's scientific panel will judge entries.
Once the grant is awarded, Everest Biotech's team will work with you to pick two peptide antigens for each target protein, synthesise it and then immunise goats.
You will receive 2mg of affinity-purified goat polyclonal antibody against each peptide at no cost.
Everest Biotech will commercialise the remainder of the batch.
Affinity-purified anti-peptide polyclonal antibodies come closest to monoclonal antibodies, yet have higher affinity and are better suited for a range of applications.
Goats produce larger batches than rabbits and, therefore, their antibodies are preferred over other polyclonal antibodies for bulk applications where monoclonal antibodies fail.
